BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Le Rolle AF, Chiu TK, Zeng Z, Shia J, Weiser MR, Paty PB, Chiu VK. Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation. Oncotarget 2016;7:2159-74. [PMID: 26744320 DOI: 10.18632/oncotarget.6818] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Kubara K, Yamazaki K, Ishihara Y, Naruto T, Lin HT, Nishimura K, Ohtaka M, Nakanishi M, Ito M, Tsukahara K, Morio T, Takagi M, Otsu M. Status of KRAS in iPSCs Impacts upon Self-Renewal and Differentiation Propensity. Stem Cell Reports 2018;11:380-94. [PMID: 29983389 DOI: 10.1016/j.stemcr.2018.06.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
2 Ternet C, Kiel C. Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage. Cell Commun Signal 2021;19:31. [PMID: 33691728 DOI: 10.1186/s12964-021-00712-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kong X, Li Y, Zhang X. Increased Expression of the YPEL3 Gene in Human Colonic Adenocarcinoma Tissue and the Effects on Proliferation, Migration, and Invasion of Colonic Adenocarcinoma Cells In Vitro via the Wnt/b-Catenin Signaling Pathway. Med Sci Monit 2018;24:4767-75. [PMID: 29988027 DOI: 10.12659/MSM.908173] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Brandl L, Kirstein N, Neumann J, Sendelhofert A, Vieth M, Kirchner T, Menssen A. The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target. Med Oncol 2018;36:5. [PMID: 30460421 DOI: 10.1007/s12032-018-1225-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
5 Borah PK, Das AS, Mukhopadhyay R, Sarkar A, Duary RK. Macromolecular design of folic acid functionalized amylopectin–albumin core–shell nanogels for improved physiological stability and colon cancer cell targeted delivery of curcumin. Journal of Colloid and Interface Science 2020;580:561-72. [DOI: 10.1016/j.jcis.2020.07.056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Parizadeh SM, Jafarzadeh-Esfehani R, Hassanian SM, Parizadeh SMR, Vojdani S, Ghandehari M, Ghazaghi A, Khazaei M, Shahidsales S, Rezayi M, Asgharzadeh F, Ghayour-Mobarhan M, Ferns GA, Avan A. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer. Int J Biochem Cell Biol 2019;110:75-83. [PMID: 30818083 DOI: 10.1016/j.biocel.2019.02.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
7 Naseem M, Cao S, Yang D, Millstein J, Puccini A, Loupakis F, Stintzing S, Cremolini C, Tokunaga R, Battaglin F, Soni S, Berger MD, Barzi A, Zhang W, Falcone A, Heinemann V, Lenz HJ. Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patients. Sci Rep 2021;11:12191. [PMID: 34108518 DOI: 10.1038/s41598-021-91330-z] [Reference Citation Analysis]
8 Fesler A, Guo S, Liu H, Wu N, Ju J. Overcoming chemoresistance in cancer stem cells with the help of microRNAs in colorectal cancer. Epigenomics 2017;9:793-6. [DOI: 10.2217/epi-2017-0041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
9 Margetis N, Kouloukoussa M, Pavlou K, Vrakas S, Mariolis-Sapsakos T. K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas. In Vivo 2017;31:527-42. [PMID: 28652417 DOI: 10.21873/invivo.11091] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
10 László L, Kurilla A, Takács T, Kudlik G, Koprivanacz K, Buday L, Vas V. Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology. Cells 2021;10:667. [PMID: 33802849 DOI: 10.3390/cells10030667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Basnet U, Patil AR, Kulkarni A, Roy S. Role of Stress-Survival Pathways and Transcriptomic Alterations in Progression of Colorectal Cancer: A Health Disparities Perspective. Int J Environ Res Public Health 2021;18:5525. [PMID: 34063993 DOI: 10.3390/ijerph18115525] [Reference Citation Analysis]
12 Brown G. Oncogenes, Proto-Oncogenes, and Lineage Restriction of Cancer Stem Cells. Int J Mol Sci 2021;22:9667. [PMID: 34575830 DOI: 10.3390/ijms22189667] [Reference Citation Analysis]
13 Rao DD, Luo X, Wang Z, Jay CM, Brunicardi FC, Maltese W, Manning L, Senzer N, Nemunaitis J. KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplex. PLoS One 2018;13:e0193644. [PMID: 29851957 DOI: 10.1371/journal.pone.0193644] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
14 Thornton AM, Fang L, Lo A, McSharry M, Haan D, O'Brien C, Berger AH, Giannakis M, Brooks AN. eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants. PLoS Comput Biol 2021;17:e1009132. [PMID: 34214079 DOI: 10.1371/journal.pcbi.1009132] [Reference Citation Analysis]
15 Fernández-fernández FJ. Antineoplastic potential of metformin in colorectal cancer. European Journal of Internal Medicine 2017;37:e22. [DOI: 10.1016/j.ejim.2016.08.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
16 Chiu VK, Le Rolle AF. Cancer comes of age embryonically. Aging (Albany NY) 2016;8:835-6. [PMID: 27191151 DOI: 10.18632/aging.100959] [Reference Citation Analysis]
17 Saliani M, Jalal R, Ahmadian MR. From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers. Cancer Biol Med 2019;16:435-61. [PMID: 31565476 DOI: 10.20892/j.issn.2095-3941.2018.0530] [Cited by in F6Publishing: 6] [Reference Citation Analysis]